Company Financials

Elanco Animal Health Incorporated Financials

United States dollar

business Elanco Animal Health Incorporated Company Profile

Main Stock Listing

NYSE: ELAN

Market Capitalization $11.19 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 321.71
Forward PE 21.74
Price to Sales TTM $2.44
Price to Book MRQ $1.66
Enterprise to Revenue 3.27
Enterprise to EBITDA 17.02

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.78%
Operating Margin 2.38%
Return on Assets TTM 1.15%
Return on Equity TTM 0.54%

Income Statement

Revenue TTM $4,591,000,064
Revenue per Share TTM $9.26
Quarterly Revenue Growth 10.40%
Gross Profit TTM $2,523,000,064
EBITDA $882,000,000
Net Income to Common TTM $36,000,000
Diluted EPS TTM $0.07
Quarterly Earnings Growth YoY 10.39%

Balance Sheet

Total Cash MRQ $505,000,000
Total Cash per Share MRQ $1.02
Total Debt MRQ $
Total Debt to Equity MRQ 64.07
Current Ratio MRQ 2.40
Book Value per Share MRQ $13.58

Cash Flow

Operating Cash Flow TTM $629,000,000
Levered Free Cash Flow TTM $504,124,992

ELAN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 496,830,457
Float Shares 492,878,628
Avg 10 Volume 5,502,980
Avg 30 Volume None
Shares Short 20,779,472
Short Ratio 4.05
Short % of Shares 5.78%
% Held by Insiders 1.07%
% Held by Institutions 116.40%

Stock Price Summary

Beta 1.86
Fifty Two Week Low $8.02
Fifty Two Week High $23.70
Fifty Two Week Change 47.07%
Day 50 MA $22.10
Day 200 MA $16.48

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date